IceCure Medical Ltd.
Develops cryoablation tech for minimally invasive destruction of benign and cancerous tumors.
ICCM | US
Overview
Corporate Details
- ISIN(s):
- IL0011224156
- LEI:
- Country:
- United States of America
- Address:
- 7 HA'ESHEL ST., POB 3163, 38900 CAESAREA
- Website:
- https://icecure-medical.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
IceCure Medical Ltd. is a medical device company specializing in the development and commercialization of cryoablation technology for tumor destruction. The company's flagship product, the ProSense® Cryoablation System, provides a minimally invasive alternative to surgical tumor removal. Utilizing proprietary liquid nitrogen (LN2) technology, the system precisely freezes and destroys both benign and cancerous tumors. The procedure offers patients and physicians benefits including rapid treatment, minimal recovery time, and favorable cosmetic results. IceCure's primary focus is on treating tumors, with significant clinical evidence and regulatory approvals for its application in early-stage breast cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IceCure Medical Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IceCure Medical Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IceCure Medical Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
